As we look ahead to the UN Summit on the Sustainable Development Goals in 2027 and continue to engage with global drug policy, there are several important opportunities for civil society to take part in shaping the future. We encourage our members and partners to join these upcoming sessions and share your perspectives.

Unlock the Future – Global Brainstorm Sessions

The Unlock the Future coalition, hosted by the UN Foundation, is convening regional brainstorms to reimagine global cooperation and ensure youth, communities, and civil society voices are included in preparations for the 2027 UN Summit on the SDGs.

Session dates and times:

  • Sept 3, 2025 – Europe (9:00–10:15 AM ET) | North America (12:00–1:15 PM ET)

  • Sept 4, 2025 – Asia (8:00–9:15 AM ET) | Pacific (7:00–8:15 PM ET)

  • Sept 5, 2025 – Middle East & Africa (9:00–10:15 AM ET) | Latin America & Caribbean (12:00–1:15 PM ET)

These sessions will mobilize ideas, shape inclusive national visions, and provide a platform to share community-driven solutions for the future of the UN.

World Drug Report 2025 – Civil Society Webinar

Join the World Drug Report 2025 Webinar for Civil Society on Thursday, 4 September 2025, 15:00–16:30 CEST.

The webinar will provide a space to:

  • Share perspectives and experiences

  • Ask questions about the 2025 Report

  • Engage in dialogue on key findings

This is an important opportunity to ensure civil society voices are part of the global conversation on drug trends, policies, and responses.

👉 Learn more about the World Drug Report

Share Your Feedback – World Drug Report 2025

UNODC is inviting civil society stakeholders to provide feedback on the 2025 World Drug Report and suggest emerging issues to address in the 2026 edition.

  • The survey takes just 6–8 minutes

  • Deadline: Monday, 8 September 2025 (midnight Vienna time)

Your insights will help strengthen the next report and ensure it reflects diverse perspectives from prevention, treatment, recovery, and community fields.

👉 Complete the survey here

These opportunities are critical for ensuring that science-based prevention, treatment, and recovery remain central in global drug policy discussions. We strongly encourage our members to engage, share their expertise, and make their voices heard.